Evidence map›Paper›PMID 23960644›Full record

ArticleJournal of the Saudi Heart Association2011

Tenecteplase in prosthetic mitral valve thrombosis.

Masood Ayyub Ghori, Sherif Bakir, Samer Ellahham, Adnan Al Nassir, Abdulmajeed Al Zubaidi, Norbert Augustin, Moataz Ayman Abdelaziz, Nicolas Patrick Turrin, Wael Abdulrahman Al Mahmeed

Open access · diamondAbstract read
In one paragraph

Article in Journal of the Saudi Heart Association, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Masood Ayyub GhoriCardiac Science Department, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Sherif Bakir
Samer Ellahham
Adnan Al Nassir
Abdulmajeed Al Zubaidi
Norbert Augustin
Moataz Ayman Abdelaziz
Nicolas Patrick Turrin
Wael Abdulrahman Al Mahmeed
Shaikh Khalifa Medical City · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the few reported cases of prosthetic mitral valve thrombosis, where surgical intervention was considered as high risk, fibrinolytic therapy had proved life saving. The authors present clinical, laboratory, and imaging data from such a patient, with prosthetic mitral valve thrombosis and its successful management with tenecteplase. The use of tenecteplase as a viable fibrinolytic agent for the first time was justified, due to the lack of immunogenicity concerns compared to streptokinase.

Indexed as

Prosthetic valveTenecteplaseThrombosis

Identifiers

PMID23960644
PMCPMC3727512
OpenAlexW2145435825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.